Updated results of a phase I/II study of inotuzumab ozogamicin in combination with low-intensity chemotherapy (mini-hyper-CVD) as frontline therapy for older patients with acute lymphoblastic leukemia.

被引：1
|
作者：
Short, Nicholas James
Kantarjian, Hagop M.
O'Brien, Susan Mary
Ravandi, Farhad
Thomas, Deborah A.
Garcia-Manero, Guillermo
Daver, Naval Guastad
Borthakur, Gautam
Jain, Nitin
Konopleva, Marina
Sasaki, Koji
Pemmaraju, Naveen
Alvarado, Yesid
Jacob, Jovitta
Garris, Rebecca
Thompson, Philip A.
Cortes, Jorge E.
Jabbour, Elias
机构：
[1] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA
[3] Univ Calif Irvine, Irvine, CA USA
[4] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.7014
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7014
引用
收藏
页数：5
相关论文
共 50 条
  • [1] INOTUZUMAB OZOGAMICIN IN COMBINATION WITH LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) AS FRONTLINE THERAPY FOR OLDER PATIENTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA: UPDATED RESULTS FROM A PHASE I/II TRIAL
    Short, N.
    Kantarjian, H.
    O'Brien, S.
    Ravandi, F.
    Thomas, D.
    Garcia-Manero, G.
    Daver, N.
    Borthakur, G.
    Jain, N.
    Konopleva, M.
    Sasaki, K.
    Pemmaraju, N.
    Alvarado, Y.
    Jacob, J.
    Garris, R.
    Thompson, P.
    Cortes, J.
    Jabbour, E.
    HAEMATOLOGICA, 2017, 102 : 34 - 35
  • [2] Frontline Inotuzumab Ozogamicin with Low-intensity Chemotherapy (mini-hyper-CVD) in Older Patients with Acute Lymphoblastic Leukemia (ALL): Updated Results of a Phase I/II Trial
    Maiti, Abhishek
    Kantarjian, Hagop
    O'Brien, Susan
    Ravandi, Farhad
    Short, Nicholas
    Thomas, Deborah
    Garcia-Manero, Guillermo
    Daver, Naval
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Sasaki, Koji
    Pemmaraju, Naveen
    Alvarado, Yesid
    Jacob, Jovitta
    Garris, Rebecca
    Thompson, Philip
    Cortes, Jorge
    Jabbour, Elias
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S255 - S256
  • [3] Frontline Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Acute Lymphoblastic Leukemia (ALL)
    Jabbour, Elias
    O'Brien, Susan
    Sasaki, Koji
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Jacob, Jovitta
    Garris, Rebecca
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2015, 126 (23)
  • [4] Inotuzumab Ozogamicin In Combination With Low-Intensity Chemotherapy (Mini-hyper-CVD) As Frontline Therapy For Older Patients (≥60 years) With Acute Lymphoblastic Leukemia (ALL)
    Jain, Nitin
    O'Brien, Susan
    Thomas, Deborah A.
    Jabbour, Elias
    Fader, Stefan
    Ravandi, Farhad
    Borthakur, Gautam
    York, Sergernne
    Garris, Rebecca
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2013, 122 (21)
  • [5] Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Frontline Therapy for Older Patients (≥60 years) with Acute Lymphoblastic Leukemia (ALL)
    Jabbour, Elias
    O'Brien, Susan
    Thomas, Deborah A.
    Sasaki, Koji
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    York, Sergernne
    Garris, Rebecca
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2014, 124 (21)
  • [6] Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Frontline Therapy for Older Patients with Acute Lymphoblastic Leukemia (ALL): Interim Result of a Phase II Clinical Trial
    Sasaki, Koji
    Jabbour, Elias J.
    O'Brien, Susan M.
    Ravandi, Farhad
    Thomas, Deborah A.
    Garcia-Manero, Guillermo
    Daver, Naval
    Borthakur, Gautam
    Jain, Nitin
    Konopleva, Marina
    Short, Nicholas J.
    Pemmaraju, Naveen
    Alvarado, Yesid
    Jacob, Jovitta
    Garris, Rebecca
    Thompson, Philip A.
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2016, 128 (22)
  • [7] INOTUZUMAB OZOGAMICIN IN COMBINATION WITH LOW-INTENSITY CHEMOTHERAPY (MINI-HYPER-CVD) FOR THE FRONTLINE THERAPY IN ELDERLY PATIENTS (≥60 YEARS) WITH ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Jabbour, E.
    O'Brien, S.
    Thomas, D.
    Sasaki, K.
    Garcia-Manero, G.
    Konopleva, M.
    Kadia, T.
    Ravandi, F.
    Borthakur, G.
    Garris, R.
    Cortes, J.
    Kantarjian, H.
    HAEMATOLOGICA, 2015, 100 : 7 - 7
  • [8] A Phase I/II Study of Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) for Older Patients with Newly Diagnosed Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
    Short, Nicholas J.
    Kantarjian, Hagop M.
    Ravandi, Farhad
    Huang, Xuelin
    Jain, Nitin
    Daver, Naval
    Thomas, Deborah A.
    Pemmaraju, Naveen
    Khouri, Rita
    Khoury, Joseph David
    Jorgensen, Jeffrey L.
    Alvarado, Yesid
    Sasaki, Koji
    Konopleva, Marina
    Garcia-Manero, Guillermo
    Kadia, Tapan
    Cortes, Jorge E.
    Benton, Christopher B.
    Borthakur, Gautam
    Burger, Jan A.
    Ohanian, Maro
    Wierda, William G.
    Estrov, Zeev
    Kornblau, Steven
    DiNardo, Courtney D.
    Ferrajoli, Alessandra
    Jacob, Jovitta
    Manzoor, Ameena
    Garris, Rebecca
    O'Brien, Susan M.
    Jabbour, Elias J.
    BLOOD, 2017, 130
  • [9] Inotuzumab Ozogamicin (IO) in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) as Frontline Therapy for Older Patients (pts) and as Salvage Therapy for Adult with Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL)
    Jabbour, Elias
    O'Brien, Susan
    Thomas, Deborah
    Sasaki, Koji
    Garcia-Manero, Guillermo
    Ravandi, Farhad
    Borthakur, Gautam
    York, Sergermne
    Garris, Rebecca
    Cortes, Jorge
    Kantarjian, Hagop
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2015, 15 : S171 - S171
  • [10] Inotuzumab Ozogamicin in Combination with Low-Intensity Chemotherapy (mini-hyper-CVD) As Salvage Therapy for Adult Patients with Refractory/Relapse (R/R) Acute Lymphoblastic Leukemia (ALL)
    Jabbour, Elias
    O'Brien, Susan
    Thomas, Deborah A.
    Sasaki, Koji
    Garcia-Manero, Guillermo
    Kadia, Tapan
    Jain, Nitin
    York, Sergernne
    Garris, Rebecca
    Cortes, Jorge E.
    Kantarjian, Hagop M.
    BLOOD, 2014, 124 (21)
12345